Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study Comparing Preventive Reversal of Vitamine K Antagonist Versus Reversion Only in Case of Intracranial Bleeding in Patients Receiving Vitamine K Antagonist Treatment

NCT01961804 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT01961804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01961804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study Comparing Preventive Reversal of Vitamine K Antagonist Versus Reversion Only in Case of Intracranial Bleeding in Patients Receiving Vitamine K Antagonist Treatment
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2014
Completion date
September 3, 2020
Enrollment
202 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation; intravascular, craniocerebral trauma, haemorrhage